Literature DB >> 15778597

Scleral contact lenses: the expanding role.

Kenneth W Pullum1, Mark A Whiting, Roger J Buckley.   

Abstract

PURPOSE: The purpose of this study was to describe the current indications for scleral contact lens (ScCL) management at Moorfields Eye Hospital, London.
METHODS: A database of 1003 patients (1560 eyes) seen between September 1999 and May 2003, either assessed for an ScCL trial or to follow up previously issued lenses, was analyzed.
RESULTS: The major contact lens indication groups were keratoconus or other primary corneal ectasia (PCE), corneal transplant, and ocular surface disease (OSD). The 3 main small groups were aphakia, myopia, and ptosis. A total of 538 patients continued lens wear in 1 or both eyes, for a total of 808 eyes. The total numbers of eyes for each contact lens indication were PCE, 496 (61.4%); corneal transplant, 150 (18.6%); OSD, 91 (11.4%); aphakia, 17 (2.1%); myopia 21 (2.6%); ptosis 14 (1.7%); and a miscellaneous indication, 19 (2.2%). The percentages were similar to those of the total group of 1560 eyes. Seven hundred twenty lenses (89.1%) were rigid gas permeable (RGP), 708 were nonventilated, and 12 were fenestrated; 88 (10.9%) were ventilated polymethylmethacrylate or ptosis props.
CONCLUSIONS: ScCLs continue to play a significant role in the management of corneal abnormalities, especially PCE, corneal transplant, and OSD. The great majority of lenses in use were nonventilated RGP designs.

Entities:  

Mesh:

Year:  2005        PMID: 15778597     DOI: 10.1097/01.ico.0000148311.94180.6b

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  24 in total

Review 1.  Current perspectives in the management of keratoconus with contact lenses.

Authors:  Li Lim; Elizabeth Wen Ling Lim
Journal:  Eye (Lond)       Date:  2020-07-08       Impact factor: 3.775

2.  A Comparison of Three Methods to Increase Scleral Contact Lens On-Eye Stability.

Authors:  Anita Ticak; Jason D Marsack; Darren E Koenig; Ayeswarya Ravikumar; Yue Shi; Lan Chi Nguyen; Raymond A Applegate
Journal:  Eye Contact Lens       Date:  2015-11       Impact factor: 2.018

3.  Wavefront-guided scleral lens prosthetic device for keratoconus.

Authors:  Ramkumar Sabesan; Lynette Johns; Olga Tomashevskaya; Deborah S Jacobs; Perry Rosenthal; Geunyoung Yoon
Journal:  Optom Vis Sci       Date:  2013-04       Impact factor: 1.973

4.  Wavefront-guided scleral lens correction in keratoconus.

Authors:  Jason D Marsack; Ayeswarya Ravikumar; Chi Nguyen; Anita Ticak; Darren E Koenig; James D Elswick; Raymond A Applegate
Journal:  Optom Vis Sci       Date:  2014-10       Impact factor: 1.973

5.  Therapeutic use of mini-scleral lenses in a patient with Graves' ophthalmopathy.

Authors:  Jennifer S Harthan
Journal:  J Optom       Date:  2013-01-09

6.  Boston ocular surface prosthesis: an Indian experience.

Authors:  Varsha Madanlal Rathi; Preeji Sudharman Mandathara; Srikanth Dumpati; Pravin K Vaddavalli; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

Review 7.  Dry Eye Management: Targeting the Ocular Surface Microenvironment.

Authors:  Xiaobo Zhang; Vimalin Jeyalatha M; Yangluowa Qu; Xin He; Shangkun Ou; Jinghua Bu; Changkai Jia; Junqi Wang; Han Wu; Zuguo Liu; Wei Li
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

8.  Clinical Performance of Toris K Contact Lens in Patients with Moderate to Advanced Keratoconus: A Real Life Retrospective Analysis.

Authors:  Ihsan Yilmaz; Ferah Ozcelik; Berna Basarir; Gokhan Demir; Gonul Durusoy; Muhittin Taskapili
Journal:  J Ophthalmol       Date:  2016-04-06       Impact factor: 1.909

Review 9.  Scleral lens for keratoconus: technology update.

Authors:  Varsha M Rathi; Preeji S Mandathara; Mukesh Taneja; Srikanth Dumpati; Virender S Sangwan
Journal:  Clin Ophthalmol       Date:  2015-10-28

10.  Morselized Amniotic Membrane Tissue for Refractory Corneal Epithelial Defects in Cicatricial Ocular Surface Diseases.

Authors:  Anny M S Cheng; Lorraine Chua; Victoria Casas; Scheffer C G Tseng
Journal:  Transl Vis Sci Technol       Date:  2016-05-18       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.